Eton Pharmaceuticals, Inc. (ETON)
NASDAQ: ETON · Real-Time Price · USD
55.36
+3.38 (6.50%)
At close: Oct 2, 2026, 4:00 PM EDT
55.81
+0.45 (0.82%)
After-hours: Oct 2, 2026, 7:43 PM EDT
Eton Pharmaceuticals Employees
Eton Pharmaceuticals had 44 employees as of December 31, 2025. The number of employees increased by 13 or 41.94% compared to the previous year.
Employees
44
Change (1Y)
13
Growth (1Y)
41.94%
Revenue / Employee
$2,399,886
Profits / Employee
$288,364
Market Cap
1.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 44 | 13 | 41.94% |
| Dec 31, 2024 | 31 | 1 | 3.33% |
| Dec 31, 2023 | 30 | 2 | 7.14% |
| Dec 31, 2022 | 28 | 11 | 64.71% |
| Dec 31, 2021 | 17 | 1 | 6.25% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Trulieve Cannabis | 5,000 |
| Phibro Animal Health | 2,605 |
| Alvotech | 1,279 |
| ANI Pharmaceuticals | 970 |
| Prestige Consumer Healthcare | 890 |
| Cronos Group | 610 |
ETON News
- 4 days ago - Eton Pharmaceuticals announces U.S. availability of Impavido - TheFly
- 4 days ago - Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO® (miltefosine) Capsules - GlobeNewsWire
- 18 days ago - Eton Pharmaceuticals participates in a conference call with Craig-Hallum - TheFly
- 18 days ago - Eton Pharmaceuticals management to meet with Craig-Hallum - TheFly
- 5 weeks ago - Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Eton Pharmaceuticals participates in a conference call with Craig-Hallum - TheFly
- 6 weeks ago - Eton Pharmaceuticals reports Q2 non-GAAP EPS 43c, consensus 19c - TheFly
- 6 weeks ago - Eton Pharmaceuticals sees FY26 revenue exceeding $145M consensus $121.32M - TheFly